CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 56 enrolled
Drug / intervention
Korlym (mifepristone) +1 moredrug
Likely dose
Korlym (mifepristone) 600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01548417
NCT01548417Phase 2Completed
CompareCT.gov

Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists

The Scripps Research Institute·interventional·Posted Mar 8, 2012·Updated Jun 24, 2016

In Brief

A Phase 2 clinical trial evaluating Korlym (mifepristone) and Sugar Pill for Alcoholism. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The primary hypotheses under test are that alcohol dependent subjects treated with mifepristone will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 8, 2012
Enrollment StartMar 1, 2012
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 14.3 years ago

Interventions

Korlym (mifepristone)drug

600 mg/day, oral pill, 7 days

Sugar Pilldrug

600 mg/day, oral pill, 7 days